Prudential Financial’s vTv Therapeutics VTVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$377K Buy
+12,218
New +$396K ﹤0.01% 2077
2023
Q1
– Sell
-260
Closed -$6.78K – 2676
2022
Q4
$6.78K Sell
260
-740
-74% -$24.5K ﹤0.01% 2586
2022
Q3
$39K Hold
1,000
– – ﹤0.01% 2583
2022
Q2
$30K Buy
+1,000
New +$25.6K ﹤0.01% 2619

Other funds holding VTVT

Prudential Financial's VTVT Position: Q3 2026 in Review

Prudential Financial opened a new position in vTv Therapeutics (VTVT) in Q3 2026: 12,218 shares worth $377K. The stake represents ﹤0.01% of the portfolio and ranks #2077 among its holdings. This is a return to the name: Prudential Financial previously reported a position in VTVT as recently as Q4 2022.

Prudential Financial first reported a position in VTVT in Q2 2022 and has held it in 4 quarters since. 38 funds tracked by Wall St. Rank hold VTVT as of Q3 2026.

  • Prudential Financial held 12,218 shares of vTv Therapeutics worth $377K as of Q3 2026.
  • vTv Therapeutics was a new Prudential Financial position in Q3 2026.
  • vTv Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q3 2026, its #2077 holding.
  • Prudential Financial first reported a position in vTv Therapeutics in Q2 2022 and has held it in 4 quarters since.
  • 38 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2026.

Based on Prudential Financial's 13F filing for Q3 2026, filed 16 Nov 2026.